C

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Vice President - Pharmacovigilance & Risk Management

Biology & BiotechConfirmed live in the last 24 hours
Full-timeHampton, NJ, USAIn-person

About the Job

Requirements

  • At least 15 years of experience within the pharmaceutical or biotechnology industry, including significant leadership experience in pharmacovigilance and drug safety.
  • Deep expertise in global pharmacovigilance regulations, safety surveillance, and risk management across clinical development and post-marketing environments.
  • Experience supporting late-stage development programs, regulatory submissions, or product launches.
  • Proven ability to lead and scale pharmacovigilance organizations within a growing biotechnology or pharmaceutical company.
  • Strong scientific and clinical acumen, including the ability to synthesize and communicate complex safety information.
  • Demonstrated success working cross-functionally and influencing within matrixed organizations.
  • An MD is required, with a specialty and/or experience managing drug safety.

Responsibilities

  • Provide overall strategic leadership and direction for the global Pharmacovigilance and Risk Management function.
  • Develop and execute the company’s global safety strategy across clinical and future commercial programs.
  • Lead the continued evolution of pharmacovigilance infrastructure, systems, processes, and governance to support organizational growth and commercialization readiness.
  • Serve as the senior safety advisor to executive leadership and cross-functional teams.
  • Oversee individual case safety report processing and medical review, signal detection and management, aggregate safety analysis and reporting, benefit-risk assessments, and risk management planning and mitigation strategies.
  • Oversee preparation and review of safety-related regulatory submissions and responses to global health authorities.
  • Ensure timely identification, evaluation, escalation, and communication of safety risks across programs.
  • Maintain expertise in global pharmacovigilance regulations, guidance, and industry best practices.
  • Ensure compliance with FDA, EMA, ICH, and other applicable global safety reporting requirements.
  • Lead inspection readiness and support regulatory inspections and audits related to pharmacovigilance.
  • Partner with Clinical Development, Clinical Operations, Regulatory Affairs, Biostatistics, Medical Affairs, Quality, and Commercial organizations on safety-related strategy and execution.
  • Contribute to development programs, regulatory submissions, labeling discussions, and launch planning activities.
  • Support Safety Governance Committees and cross-functional safety review forums.
  • Lead departmental operations, including organizational design, resourcing, vendor oversight, standard operating procedures, training, technology, and budget management.
  • Recruit, develop, and retain high-performing pharmacovigilance talent.
  • Foster a collaborative, patient-focused, and scientifically rigorous culture within the safety organization.
  • Drive operational excellence and continuous process improvement across the function.

Desired Qualifications

  • Experience in immunology, allergy, dermatology, or related therapeutic areas.
  • Experience supporting global development programs and commercialization readiness.
  • Experience with safety systems implementation and pharmacovigilance operational scaling in emerging biotechnology environments.

About the Company

Celldex Therapeutics

Develops antibody-based therapies targeting inflammatory diseases

Celldex Therapeutics develops antibody-based therapies for inflammatory, allergic, and autoimmune diseases, focusing on mast cell biology. Its lead program barzolvolimab is a humanized monoclonal antibody that inhibits KIT, reducing mast cell activity and inflammation; its pipeline includes other antibodies designed to engage the immune system or modulate disease pathways. The company leverages partnerships and licensing in addition to developing its own therapies to create a breadth of programs in its target areas. Its goal is to deliver therapies that lessen inflammation and autoimmune activity by targeting mast cells and related signaling pathways.

Company size
201-500
Company stage
IPO
Headquarters
Hampton, NJ
Founded
1983

Recently Posted Jobs

Explore more opportunities at Celldex Therapeutics

See more jobs